<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">lvrach</journal-id><journal-title-group><journal-title xml:lang="ru">Лечащий Врач</journal-title><trans-title-group xml:lang="en"><trans-title>Lechaschi Vrach</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-5175</issn><issn pub-type="epub">2687-1181</issn><publisher><publisher-name></publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51793/OS.2025.28.11.001</article-id><article-id custom-type="elpub" pub-id-type="custom">lvrach-1493</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПСИХОНЕВРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PSYCHONEUROLOGY</subject></subj-group></article-categories><title-group><article-title>Беспокойство о здоровье — искоренять? поддерживать? дозировать?</article-title><trans-title-group xml:lang="en"><trans-title>Health anxiety — eradicate? support? dose?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5116-836X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильева</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasileva</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Васильева Анна Владимировна, д.м.н., руководитель международного отдела, главный научный сотрудник отделения лечения пограничных психических расстройств и психотерапии; профессор кафедры психотерапии и сексологии</p><p>192019, Санкт-Петербург, ул. Бехтерева, 3</p><p>191015, Санкт-Петербург, ул. Кирочная, 41</p></bio><bio xml:lang="en"><p>Anna V. Vasileva, Dr. of Sci. (Med.), Head of the International Department, Chief Researcher at the Department of Borderline Mental Disorders Treatment and Psychotherapy; Professor of the Department of Psychotherapy and Sexology</p><p>3 Bekhtereva str., Saint Petersburg, 192019</p><p>41 Kirochnaya str., Saint Petersburg, 191015</p></bio><email xlink:type="simple">annavdoc1@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр психиатрии и неврологии имени В. М. Бехтерева; Северо-Западный государственный медицинский университет имени И. И. Мечникова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V. M. Bekhterev National Medical Research Center of Psychiatry and Neurology; I. I. Mechnikov Northwestern State Medical University, Saint Petersburg</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>11</month><year>2025</year></pub-date><volume>1</volume><issue>11</issue><fpage>11</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Васильева А.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Васильева А.В.</copyright-holder><copyright-holder xml:lang="en">Vasileva A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.lvrach.ru/jour/article/view/1493">https://journal.lvrach.ru/jour/article/view/1493</self-uri><abstract><sec><title>Введение</title><p>Введение. Беспокойство о здоровье является специфическим психологическим конструктом, который во многом определяет поведение человека в отношении его собственного здоровья, тем самым влияя на соблюдение профилактических мер и приверженность лечению, чем определяется его междисциплинарная значимость. Задача врача любой специальности – привлечь внимание пациента к необходимости заботиться о своем здоровье, используя весь арсенал собственных коммуникативных навыков. В настоящее время активное развитие цифровых технологий кардинальным образом влияет на информационное поведение человека, что находит отражение и в поиске медицинской информации, и в формировании внутренней картины болезни, и в появлении новых вариантов беспокойства о здоровье, которые освещаются в данной статье. Для специалистов цифровое пространство и появление искусственного интеллекта, позволяющего оперативно обрабатывать огромные массивы данных, открывают возможности новых форм социального слушания. Сегодня появилась возможность по-новому оценить отношение пациентов к назначенному лечению, а также особенности формирования их мировоззренческих сетей. Полученная информация может быть использована для разработки таргетных психосоциальных интервенций, направленных на повышение приверженности назначенному лечению.</p></sec><sec><title>Заключение</title><p>Заключение. В практике специалистов соматического профиля довольно часто встречаются как нозогенные тревожные расстройства, связанные с внутренней картиной болезни пациента, страхом прогрессирования заболевания, так и собственно тревожные расстройства, манифестирующие в соматической плоскости, нозофобии, ипохондрические состояния. Комплексное лечение в таких случаях должно включать сочетание психо- и фармакотерапии, где анксиолитики могут рассматриваться как препараты выбора.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Health anxiety is considered to be a specific psychological construct, that determines the individual health behavior making a crucial impact on the treatment adherence and prevention strategies. All mentioned above defines its interdisciplinary importance. The task of every medical doctor is to attract patients attention to the necessity of taking care of one’s health using all available professional communication skills. The recent active development of the digital technologies makes a serious impact on the ones information seeking behavior, including medical information search, creating an internal model of the illness and modern health anxiety manifestation highlighting in this article. Digital space and AI creation capable of big data speedy analyzation open for the professional’s new options of social listening. Today we have the opportunity of new evaluation of patient’s treatment choices and their mindset networks development. The accumulated data can be used for the targeted psychosocial interventions development aimed to improve the treatment adherence.</p></sec><sec><title>Conclusion</title><p>Conclusion. In the internists routine practice there is a high rate of patients with nosogenic anxiety disorders associated with the internal illness model, fear of the disease progress and also with the typical anxiety disorders manifesting in the somatic sphere, nosophobias, hypochondriac states. Their complex treatment should include combination of psychotherapy and pharmacotherapy, where anxiolytics can be considered as the treatment choice.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>тревога</kwd><kwd>беспокойство о здоровье</kwd><kwd>соматизация</kwd><kwd>цифровизация</kwd><kwd>информационная психиатрия</kwd><kwd>социальные сети</kwd><kwd>внутренняя картина болезни</kwd><kwd>анксиолитики</kwd><kwd>бензодиазепины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>anxiety</kwd><kwd>health anxiety</kwd><kwd>somatization</kwd><kwd>digitalization</kwd><kwd>nformation psychiatry</kwd><kwd>social networks</kwd><kwd>internal disease model</kwd><kwd>anxiolytics</kwd><kwd>benzodiazepines</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Health Literacy. The solid facts. Eds: Kickbusch I., Pelikan J. M., Apfel F., Tsouros A. D. WHO. Regional office. Accessed 20 September, 2025. https://www.euro.who.int/data/assets/pdf_file/0008/190655/e96854.pdf.</mixed-citation><mixed-citation xml:lang="en">Health Literacy. The solid facts. Eds: Kickbusch I., Pelikan J. M., Apfel F., Tsouros A. D. WHO. Regional office. Accessed 20 September, 2025. https://www.euro.who.int/data/assets/pdf_file/0008/190655/e96854.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сирота Н. А., Ялтонский В. М., Абросимов И. Н. и др. Клиническая психология лечебного процесса. М.: ГЭОТАР-Медиа, 2023. 400 с. S</mixed-citation><mixed-citation xml:lang="en">Sirota N. A., Yaltonsky V. M., Abrosimov I. N., et al. Clinical psychology of the treatment process. Moscow: GEOTAR-media, 2023. 400 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Калинина А. М., Куликова М. С., Шепель Р. Н., Астанина С. Ю., Концевая А. В., Драпкина О. М. Множественные поведенческие факторы риска хронических неинфекционных заболеваний: концепция сцепленного влияния. Профилактическая медицина. 2025; 28 (1): 44-49. https://doi.org/10.17116/profmed20252801144.</mixed-citation><mixed-citation xml:lang="en">Kalinina A. M., Kulikova M. S., Shepel R. N., Astanina S. Yu., Kontsevaya A. V., Drapkina O. M. Multiple behavioral risk factors for chronic noncommunicable diseases: the concept of concatenated influence. Profilakticheskaya meditsina. 2025; 28 (1): 44-49. (In Russ.) https://doi.org/10.17116/profmed20252801144.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова С. А., Баланова Ю. А., Деев А. Д. и др. Интегральная оценка приверженности здоровому образу жизни как способ мониторинга эффективности профилактических мер. Профилактическая медицина. 2018; 21 (4): 65-72.</mixed-citation><mixed-citation xml:lang="en">Shalnova S. A., Balanova Yu. A., Deev A. D., et al. Integrated assessment of adherence to a healthy lifestyle as a way of monitoring the effectiveness of preventive measures. Profilakticheskaya meditsina. 2018; 21 (4): 65-72. (In Russ.) https://doi.org/10.17116/profmed201821465.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Duda-Sikuła M., Kurpas D. Barriers and Facilitators in the Implementation of Prevention Strategies for Chronic Disease Patients-Best Practice GuideLines and Policies' Systematic Review. J Pers Med. 2023; 13 (2): 288. DOI: 10.3390/jpm13020288.</mixed-citation><mixed-citation xml:lang="en">Duda-Sikuła M., Kurpas D. Barriers and Facilitators in the Implementation of Prevention Strategies for Chronic Disease Patients-Best Practice GuideLines and Policies' Systematic Review. J Pers Med. 2023; 13 (2): 288. DOI: 10.3390/jpm13020288.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Battles J. B., Dixon N. M., Borotkanics R. J., Rabin-Fastmen B., Kaplan H. S. Sensemaking of patient safety risks and hazards. Health Serv Res. 2006; 41 (4 Pt 2): 1555-75. DOI: 10.1111/j.1475-6773.2006.00565.x.</mixed-citation><mixed-citation xml:lang="en">Battles J. B., Dixon N. M., Borotkanics R. J., Rabin-Fastmen B., Kaplan H. S. Sensemaking of patient safety risks and hazards. Health Serv Res. 2006; 41 (4 Pt 2): 1555-75. DOI: 10.1111/j.1475-6773.2006.00565.x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rhodes P., McDonald R., Campbell S., Daker-White G., Sanders C. Sensemaking and the co-production of safety: a qualitative study of primary medical care patients. Sociol Health Illn. 2016; 38 (2): 270-285. DOI: 10.1111/14679566.12368.</mixed-citation><mixed-citation xml:lang="en">Rhodes P., McDonald R., Campbell S., Daker-White G., Sanders C. Sensemaking and the co-production of safety: a qualitative study of primary medical care patients. Sociol Health Illn. 2016; 38 (2): 270-285. DOI: 10.1111/14679566.12368.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Weick K. E., Sutcliffe K. M., Obstfeld D. Organizing and the process of sensemaking. Organization Science. 2005; 16 (4): 409-421. https://doi.org/10.1287/orsc.1050.0133.</mixed-citation><mixed-citation xml:lang="en">Weick K. E., Sutcliffe K. M., Obstfeld D. Organizing and the process of sensemaking. Organization Science. 2005; 16 (4): 409-421. https://doi.org/10.1287/orsc.1050.0133.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gabbay J., le May A. Evidence based guidelines or collectively constructed "mindlines?" Ethnographic study of knowledge management in primary care. BMJ. 2004; 329 (7473): 1013. DOI: 10.1136/bmj.329.7473.1013.</mixed-citation><mixed-citation xml:lang="en">Gabbay J., le May A. Evidence based guidelines or collectively constructed "mindlines?" Ethnographic study of knowledge management in primary care. BMJ. 2004; 329 (7473): 1013. DOI: 10.1136/bmj.329.7473.1013.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kanchan S., Gaidhane A. Social Media Role and its impact on Public Health: a narrative review. Cureus. 2023; 15.</mixed-citation><mixed-citation xml:lang="en">Kanchan S., Gaidhane A. Social Media Role and its impact on Public Health: a narrative review. Cureus. 2023; 15.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Незнанов Н. Г., Васильева А. В. Цифровизация в оказании помощи в области психического здоровья. Новые возможности для специалистов и пациентов. Национальное здравоохранение. 2023; 4 (2): 15-24. https://doi.org/10.47093/2713-069X.2023.4.2.15-24.</mixed-citation><mixed-citation xml:lang="en">Neznanov N. G., Vasileva A. V. Digitalization in mental health care. New opportunities for specialists and patients. Natsionalnoe zdravookhranenie. 2023; 4 (2): 15-24. (In Russ.) https://doi.org/10.47093/2713-069X.2023.4.2.15-24.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Moorhead S. A., Hazlett D. E., Harrison L., Carroll J. K., Irwin A., Hoving C. A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res. 2013; 15: 6. 10.2196/JMIR.1933.</mixed-citation><mixed-citation xml:lang="en">Moorhead S. A., Hazlett D. E., Harrison L., Carroll J. K., Irwin A., Hoving C. A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res. 2013; 15: 6. 10.2196/JMIR.1933.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Farsi D., Martinez-Menchaca H. R., Ahmed M., Farsi N. Social media and health care (part II): narrative review of social media use by patients. J Med Internet Res. 2022; 24: e30379. 10.2196/30379.</mixed-citation><mixed-citation xml:lang="en">Farsi D., Martinez-Menchaca H. R., Ahmed M., Farsi N. Social media and health care (part II): narrative review of social media use by patients. J Med Internet Res. 2022; 24: e30379. 10.2196/30379.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mullin A., Scott M., Vaccaro G., Floresta G., Arillotta D., Catalani V., et al. Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present using Analytical and Social listening techniques. Pharm (Basel). 2024; 12: 13.</mixed-citation><mixed-citation xml:lang="en">Mullin A., Scott M., Vaccaro G., Floresta G., Arillotta D., Catalani V., et al. Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present using Analytical and Social listening techniques. Pharm (Basel). 2024; 12: 13.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hu H., Phan N. H., Geller J., Iezzi S., Vo H., Dou D., et al. An Ensemble Deep Learning Model for drug abuse detection in Sparse Twitter-Sphere. Stud Health Technol Inf. 2019; 264: 163-167.</mixed-citation><mixed-citation xml:lang="en">Hu H., Phan N. H., Geller J., Iezzi S., Vo H., Dou D., et al. An Ensemble Deep Learning Model for drug abuse detection in Sparse Twitter-Sphere. Stud Health Technol Inf. 2019; 264: 163-167.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Plan d’actions de l’ANSM visant à réduire le mésusage des. benzodiazépines – Point d’information – ANSM: Agence nationale de sécurité du médicament et des produits de santé. https://archiveansm.integra.fr/S-informer/Pointsd-information-Points-d-information/Plan-d-actions-de-l-ANSM-visant-areduire-le-mesusage-des-benzodiazepines-Point-d-information. Accessed 19 Oct. 2025.</mixed-citation><mixed-citation xml:lang="en">Plan d’actions de l’ANSM visant à réduire le mésusage des. benzodiazépines – Point d’information – ANSM: Agence nationale de sécurité du médicament et des produits de santé. https://archiveansm.integra.fr/S-informer/Pointsd-information-Points-d-information/Plan-d-actions-de-l-ANSM-visant-areduire-le-mesusage-des-benzodiazepines-Point-d-information. Accessed 19 Oct. 2025.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Van Hulten R., Isacson D., Bakker A., Leufkens H. G. Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf. 2003; 12: 49-53.</mixed-citation><mixed-citation xml:lang="en">Van Hulten R., Isacson D., Bakker A., Leufkens H. G. Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf. 2003; 12: 49-53.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">benzo.org.uk: Benzodiazepines: How They Work &amp; How to Withdraw, Prof CH, Ashton DM. FRCP, 2002. https://www.benzo.org.uk/manual/index.htm. Accessed 19 Oct. 2025.</mixed-citation><mixed-citation xml:lang="en">benzo.org.uk: Benzodiazepines: How They Work &amp; How to Withdraw, Prof CH, Ashton DM. FRCP, 2002. https://www.benzo.org.uk/manual/index.htm. Accessed 19 Oct. 2025.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bachhuber M. A., Hennessy S., Cunningham C. O., Starrels J. L. Increasing Benzodiazepine prescriptions and Overdose Mortality in the United States, 1996-2013. Am J Public Health. 2016; 106: 686–688.</mixed-citation><mixed-citation xml:lang="en">Bachhuber M. A., Hennessy S., Cunningham C. O., Starrels J. L. Increasing Benzodiazepine prescriptions and Overdose Mortality in the United States, 1996-2013. Am J Public Health. 2016; 106: 686–688.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sarker A., Al-Garadi M. A., Ge Y., Nataraj N., McGlone L., Jones C. M., et al. Evidence of the emergence of illicit benzodiazepines from online drug forums. Eur J Public Health. 2022; 32: 939.</mixed-citation><mixed-citation xml:lang="en">Sarker A., Al-Garadi M. A., Ge Y., Nataraj N., McGlone L., Jones C. M., et al. Evidence of the emergence of illicit benzodiazepines from online drug forums. Eur J Public Health. 2022; 32: 939.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">FDA Drug Safety Communication. FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning | FDA. https://www.fda.gov/drugs/drug-safetyand-availability/fda-drug-safety-communication-fda-warns-about-seriousrisks-and-death-when-combining-opioid-pain-or. Accessed 19 Oct. 2025.</mixed-citation><mixed-citation xml:lang="en">FDA Drug Safety Communication. FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning | FDA. https://www.fda.gov/drugs/drug-safetyand-availability/fda-drug-safety-communication-fda-warns-about-seriousrisks-and-death-when-combining-opioid-pain-or. Accessed 19 Oct. 2025.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">De Anta L., Alvarez-Mon M. Á., Pereira-Sanchez V., Donat-Vargas C. C., Lara-Abelenda F. J., Arrieta M., Montero-Torres M., García-Montero C., Fraile-Martínez Ó., Mora F., Ortega M. Á., Alvarez-Mon M., Quintero J. Assessment of beliefs and attitudes towards benzodiazepines using machine learning based on social media posts: an observational study. BMC Psychiatry. 2024; 24 (1): 659. DOI: 10.1186/s12888-024-06111-5.</mixed-citation><mixed-citation xml:lang="en">De Anta L., Alvarez-Mon M. Á., Pereira-Sanchez V., Donat-Vargas C. C., Lara-Abelenda F. J., Arrieta M., Montero-Torres M., García-Montero C., Fraile-Martínez Ó., Mora F., Ortega M. Á., Alvarez-Mon M., Quintero J. Assessment of beliefs and attitudes towards benzodiazepines using machine learning based on social media posts: an observational study. BMC Psychiatry. 2024; 24 (1): 659. DOI: 10.1186/s12888-024-06111-5.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Farrar M., Lundt L., Franey E., Yonan C. Patient perspective of tardive dyskinesia: results from a social media listening study. BMC Psychiatry. 2021; 21. 10.1186/S12888-021-03074-9.</mixed-citation><mixed-citation xml:lang="en">Farrar M., Lundt L., Franey E., Yonan C. Patient perspective of tardive dyskinesia: results from a social media listening study. BMC Psychiatry. 2021; 21. 10.1186/S12888-021-03074-9.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chart-Pascual J. P., Goena J., Lara F., Montero Torres M., Marin Napal J., Muñoz R., García Montero C., Fraile Martínez O., Ortega M. Á., Salazar de Pablo G., González Pinto A., Quintero J., Alvarez-Mon M., Álvarez-Mon M. Á. Understanding social media discourse on antidepressants: unsupervised and sentiment analysis using X. Eur Psychiatry. 2025; 68 (1): e51. DOI: 10.1192/j.eurpsy.2025.10.</mixed-citation><mixed-citation xml:lang="en">Chart-Pascual J. P., Goena J., Lara F., Montero Torres M., Marin Napal J., Muñoz R., García Montero C., Fraile Martínez O., Ortega M. Á., Salazar de Pablo G., González Pinto A., Quintero J., Alvarez-Mon M., Álvarez-Mon M. Á. Understanding social media discourse on antidepressants: unsupervised and sentiment analysis using X. Eur Psychiatry. 2025; 68 (1): e51. DOI: 10.1192/j.eurpsy.2025.10.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kisa A., Kisa S. Health conspiracy theories: a scoping review of drivers, impacts, and countermeasures. Int J Equity Health. 2025; 24 (1): 93. DOI: 10.1186/s12939-025-02451-0.</mixed-citation><mixed-citation xml:lang="en">Kisa A., Kisa S. Health conspiracy theories: a scoping review of drivers, impacts, and countermeasures. Int J Equity Health. 2025; 24 (1): 93. DOI: 10.1186/s12939-025-02451-0.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Незнанов Н. Г., Коцюбинский А. П., Коцюбинский Д. А. Информационная психиатрия – новый подход к осмыслению воздействия цифрового информационного пространства на психическое здоровье индивидуума и социума. Сообщение 1. Обозрение психиатрии и медицинской психологии имени В. М. Бехтерева. 2025; 59 (1): 18-30. https://doi.org/10.31363/2313-7053-2025-1-984.</mixed-citation><mixed-citation xml:lang="en">Neznanov N. G., Kotsyubinsky A. P., Kotsyubinsky D. A. Cyberpsychiatry is a new approach to understanding the impact of digital information space on the mental health of individuals and society. Report № 1. Obozrenie psikhiatrii i meditsinskoi psikhologii imeni V. M. Bekhtereva. 2025; 59 (1): 18-30. (In Russ.) https://doi.org/10.31363/2313-7053-2025-1-984.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Lahrach Y., Furnham A. Are modern health worries associated with medical conspiracy theories? J Psychosom Res. 2017; 99: 89-94.</mixed-citation><mixed-citation xml:lang="en">Lahrach Y., Furnham A. Are modern health worries associated with medical conspiracy theories? J Psychosom Res. 2017; 99: 89-94.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Wang D., Zhou Y., Ma F. Opinion Leaders and Structural Hole Spanners Influencing Echo Chambers in Discussions About COVID-19 Vaccines on Social Media in China: Network Analysis. J Med Internet Res. 2022; 24 (11): e40701. DOI: 10.2196/40701.</mixed-citation><mixed-citation xml:lang="en">Wang D., Zhou Y., Ma F. Opinion Leaders and Structural Hole Spanners Influencing Echo Chambers in Discussions About COVID-19 Vaccines on Social Media in China: Network Analysis. J Med Internet Res. 2022; 24 (11): e40701. DOI: 10.2196/40701.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Васильев В. В., Мухаметова А. И. Современные исследования личностно-психологических особенностей больных соматоформными расстройствами. Обозрение психиатрии и медицинской психологии имени В. М. Бехтерева. 2024; 58 (1): 30-46. https://doi.org/10.31363/23137053-2024-746.</mixed-citation><mixed-citation xml:lang="en">Vasilyev V. V., Mukhametova A. I. Modern researches of personalitypsychological features in patients with somatoform disorders. VObozrenie psikhiatrii i meditsinskoi psikhologii imeni V. M. Bekhtereva. 2024; 58 (1): 30-46. (In Russ.) https://doi.org/10.31363/2313-7053-2024-746.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Köteles F., Bárány E., Varsányi P., Bárdos G. Are modern health worries associated with somatosensory amplification, environmental attribution style, and commitment to complementary and alternative medicine? Scand J Psychol. 2012; 53 (2): 144-149. DOI: 10.1111/j.1467-9450.2011.00908.x.</mixed-citation><mixed-citation xml:lang="en">Köteles F., Bárány E., Varsányi P., Bárdos G. Are modern health worries associated with somatosensory amplification, environmental attribution style, and commitment to complementary and alternative medicine? Scand J Psychol. 2012; 53 (2): 144-149. DOI: 10.1111/j.1467-9450.2011.00908.x.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Dömötör Z., Nordin S., Witthöft M., Köteles F. Modern health worries: A systematic review. J Psychosom Res. 2019; 124: 109781. DOI: 10.1016/j.jpsychores.2019.109781.</mixed-citation><mixed-citation xml:lang="en">Dömötör Z., Nordin S., Witthöft M., Köteles F. Modern health worries: A systematic review. J Psychosom Res. 2019; 124: 109781. DOI: 10.1016/j.jpsychores.2019.109781.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Andersen J. H., Jensen J. C. Modern health worries and visits to the general practitioner in a general population sample: an 18month follow-up study. J Psychosom Res. 2012; 73 (4): 264-267. DOI: 10.1016/j.jpsychores.2012.07.007.</mixed-citation><mixed-citation xml:lang="en">Andersen J. H., Jensen J. C. Modern health worries and visits to the general practitioner in a general population sample: an 18month follow-up study. J Psychosom Res. 2012; 73 (4): 264-267. DOI: 10.1016/j.jpsychores.2012.07.007.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Костюк Г. П. Актуальные проблемы практической психиатрии: решит ли их новый порядок оказания медицинской помощи при психических расстройствах и расстройствах поведения? Национальное здравоохранение. 2023; 4 (1): 48-54.</mixed-citation><mixed-citation xml:lang="en">Kostyuk G. P. Current problems of practical psychiatry: will the new Procedure for providing medical care for mental disorders and behavioral disorders solve them? Natsionalnoe zdravookhranenie. 2023; 4 (1): 48-54. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Васильева А. В., Богушевская Ю. В., Ивченко А. И. Прогностическая оценка «избегающего врача-психиатра поведения» у больных соматизированными расстройствами, обратившихся в учреждения первичной медико-санитарной помощи. Обозрение психиатрии и медицинской психологии им. В. М. Бехтерева. 2024; 58: 4-1: 61-72. http//doi.org/10.31363/2313-7053-2024-958.</mixed-citation><mixed-citation xml:lang="en">Vasilyeva A. V., Bogushevskaya Yu. V., Ivchenko A. I. Prognostic assessment of "psychiatristavoidant behavior" in patients with somatization disorders who applied to primary health care institutions. Obozrenie psikhiatrii i meditsinskoi psikhologii imeni V. M. Bekhtereva. 2024; 58: 4-1: 61-72. http//doi.org/10.31363/2313-7053-2024-958. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Волель Б. А. Небредовая ипохондрия (обзор литературы). Психические расстройства в общей медицине. 2009; 02: 49-62.</mixed-citation><mixed-citation xml:lang="en">Volel B. A. Nebredovaya ipokhondriya (obzor literatury). Psikhicheskie rasstroistva v obshchei meditsine. 2009; 02: 49-62. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Богушевская Ю. В., Васильева А. В., Ивченко А. И. Внутренняя картина болезни и модели отношения к лечению у женщин с соматизированными расстройствами. Консультативная психология и психотерапия. 2023; 31 (4): 105-124.</mixed-citation><mixed-citation xml:lang="en">Bogushevskaya Yu. V., Vasileva A. V., Ivchenko A. I. Internal picture of the disease and models of attitude to treatment in women with somatization disorders Konsultativnaya psikhologiya i psikhoterapiya. 2023; 31 (4): 105-124. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Абросимов И. Н., Ялтонский В. М., Лисицына Т. А., Абрамкин А. А., Ламчева Е. И., Тимашков А. Ю., Лила А. М. Психологические особенности пациентов с ревматоидным артритом, имеющих выраженные тревожно-депрессивные переживания. Современная ревматология. 2025; 19 (1): 64-71. DOI: 10.14412/1996-7012-2025-1-64-71.</mixed-citation><mixed-citation xml:lang="en">Abrosimov I. N., Yaltonsky V. M., Lisitsyna T. A., Abramkin A. A., Lamcheva E. I., Timashkov A. Yu., Lila A. M. Psychological characteristics of patients with rheumatoid arthritis with severe anxiety and depression. Sovremennaya Revmatologiya. 2025; 19 (1): 64-71. DOI: 10.14412/1996-7012-2025-1-64-71.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Сирота Н. А., Московченко Д. В. Психодиагностика страха прогрессирования заболевания: результаты апробации русскоязычной версии опросника страха прогрессирования заболевания. Обозрение психиатрии и медицинской психологии имени В. М. Бехтерева. 2014; 4: 86-91.</mixed-citation><mixed-citation xml:lang="en">Sirota N. A., Moskochenko D. V. Psychodiagnostics of the fear of disease progression: results of approbation of the Russian-language version of the questionnaire of fear of disease progression. Obozrenie psikhiatrii i meditsinskoi psikhologii imeni V. M. Bekhtereva. 2014; 4: 86-91. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Васильева А. В. Пандемия и адаптационные тревожные расстройства: возможности терапии. Журнал неврологии и психиатрии им. С. С. Корсакова. 2020; 120 (5): 146-152. https://doi.org/10.17116/jnevro2020120051146.</mixed-citation><mixed-citation xml:lang="en">Vasileva A. V. Pandemia and mental adjustment disorders. Therapy options. Zhurnal nevrologii i psikhiatrii imeni S. S. Korsakova. 2020; 120 (5): 146-152. (In Russ.) https://doi.org/10.17116/jnevro2020120051146.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Астанина С. Ю., Калинина А. М., Шепель Р. Н. и др. Коммуникативные умения врача-терапевта участкового в проведении профилактического консультирования (методологический аспект). Кардиоваскулярная терапия и профилактика. 2023; 22 (1S): 7-14.</mixed-citation><mixed-citation xml:lang="en">Astanina S. Yu., Kalinina A. M., Shepel R. N., et al. Communicative skills of a district physician in conducting preventive counseling (methodological aspect). Kardiovaskulyarnaya terapiya i profilaktika. 2023; 22 (1S): 7-14. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3559.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Поплавская О. В., Цыбуля Ю. В. Современные подходы к применению Грандаксина (Тофизопама) в терапии астенических состояний. Лекарственный вестник. 2017; 1 (65), т. 11.</mixed-citation><mixed-citation xml:lang="en">Poplavskaya O. V., Tsybulya Yu. V. Modern approaches to the use of Grandaxin (Tofisopam) in the treatment of asthenic conditions. Lekarstvennyi vestnik. 2017; 1 (65), 11. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Pellow S., File S. E. Is tofisopam an atypical anxiolytic? Neurosci Biobehav Rev. 1986; 10 (2): 221-227.</mixed-citation><mixed-citation xml:lang="en">Pellow S., File S. E. Is tofisopam an atypical anxiolytic? Neurosci Biobehav Rev. 1986; 10 (2): 221-227.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Арушанян Э. Б. и соавт. Хронобиологические особенности влияния тофизопама на вариабельность сердечного ритма у человека. Экспериментальная и клиническая фармакология. 2005; 68 (4): 36-39.</mixed-citation><mixed-citation xml:lang="en">Arushanyan E. B., et al. Chronobiological features of the effect of tofisopam on heart rate variability in humans. Eksperimentalnaya i klinicheskaya farmakologiya. 2005; 68 (4): 36-39. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Kokoszka A. A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Controlled Pilot Study. Pharmaceuticals (Basel). 2024; 17 (1): 140. DOI: 10.3390/ph17010140.</mixed-citation><mixed-citation xml:lang="en">Kokoszka A. A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Controlled Pilot Study. Pharmaceuticals (Basel). 2024; 17 (1): 140. DOI: 10.3390/ph17010140.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Пасечников В. Д. и соавт. Коррекция психосоматических расстройств в комплексной терапии артериальной гипертонии у женщин в перименопаузальном периоде. Южно-Российский медицинский журнал, 2002; 3: 1-4.</mixed-citation><mixed-citation xml:lang="en">Pasechnikov V. D., et al. Correction of psychosomatic disorders in the complex therapy of arterial hypertension in women in the perimenopausal period. Yuzhno-Rossiiskii meditsinskii zhurnal. 2002; 3: 1-4. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Гольдин Б. Г., Савицкая И. В. Грандаксин в лечении тревожных расстройств у больных бронхиальной астмой. В мире лекарств. 1999; 3.</mixed-citation><mixed-citation xml:lang="en">Goldin B. G., Savitskaya I. V. Grandaxin in the treatment of anxiety disorders in patients with bronchial asthma. V mire lekarstv. 1999; 3. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Скворцов Г. Ю., Головачева Т. В. Эффективность тофизопама (Грандаксина) в лечении ИБС: клинико-инструментальное подтверждение. Клиническая фармакология и терапия. 2001; 1: 52-55.</mixed-citation><mixed-citation xml:lang="en">Skvortsov G. Yu., Golovacheva T. V. Efficiency of tofisopam (Grandaxin) in the treatment of coronary heart disease: clinical and instrumental confirmation. Klinicheskaya farmakologiya i terapiya. 2001; 1: 52-55. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Васильева А. В., Караваева Т. А., Полторак С. В., Колесова Ю. П. Принципы и алгоритмы психофармакологического лечения тревожных расстройств невротического уровня (тревожно-фобических, панического и генерализованного тревожного расстройств). Обозрение психиатрии и медицинской психологии им. В. М. Бехтерева. 2016; 1: 3-9.</mixed-citation><mixed-citation xml:lang="en">Vasileva A. V., Karavaeva T. A., Poltorak S. V., Kolesova Y. P. Neurotic level anxiety disorders (panic, generalized anxiety and anxiety-phobic disorders) pschopharmacoceutical treatment principles and algorithms. Obozrenie psikhiatrii i meditsinskoi psikhologii imeni V. M. Bekhtereva. 2016; 1: 3-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Ронаи Ш., Орос Ф., Болла К. Применение Грандаксина в амбулаторной практике. Венгер. фармакотер. 1975; 4-10.</mixed-citation><mixed-citation xml:lang="en">Ronai Sh., Oros F., Bolla K. the use of grandaxine in out-patient setting. Venger Pharmacother. 1975; 4-10. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Александровский Ю. А., Аведисова А. С., Павлова М. С. О вегетотропном эффекте Грандаксина при лечении невротических расстройств в общесоматической практике. Терапевтический архив. 1998; 10: 76-85. Alexandorvsky Y. A., Avedisova A. S., Pavlova M. S. The vegetotropic effect of grandaxine in primary care neurotic disorders treatment. Therapevticheskii arkhiv. 1998; 10: 76-85. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Alexandorvsky Y. A., Avedisova A. S., Pavlova M. S. The vegetotropic effect of grandaxine in primary care neurotic disorders treatment. Therapevticheskii arkhiv. 1998; 10: 76-85. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Вейн А. М., Артеменко А. Р., Окнин В. Ю., Поморцев И. В. Эффективность Грандаксина в коррекции психовегетативных расстройств. Клиническая медицина. 1999; 6: 41-45.</mixed-citation><mixed-citation xml:lang="en">Vein A. M., Artemenko A. P., Oknin V. Y., Pomorcev I. V. Grandaxin efficacy in the psychovegetative disorders correction. Klinicheskaya meditsina. 1999; 6: 41-45. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Васильева А. В., Караваева Т. А., Семиглазова Т. Ю. Особенности психофармакотерапии онкологических больных с тревожными расстройствами. Вопросы онкологии. 2018; 64 (5): 567-661.</mixed-citation><mixed-citation xml:lang="en">Vasileva A. V., Karavaeva T. A., Semiglazova T. Y. Specific of the psychopharmacotherapy in oncology patients with anxiety disorders. Voprosy onkologii. 2018; 64 (5): 567-661. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
